Vitamin B-12 Associated Neurological Diseases Questions & Answers

1. Gardner W, Osler W. A case of progressive pernicious anemia (Idiopathic of Addison). Can Med Surg J. 1877. 5:385-404.

2. Leichtenstein O. Uber progressive perniciose anamie bei tabeskranken. Deutsche Medizinische Wochenschrift. 1884. 10:849.

3. Lichtheim L. Zur kenntniss der perniziosen anamie. Muchen. Schweiz med wochenschr. 1887. 34:300.

4. Minnich W. Kenntnis der im Verlaufe der perniciosen anamie beobachteten spinalerkrankungen. Zeitschrift fur Klinische Medizin. 1892. 21:264-314.

5. Russell JSR, Batten FE, Collier J. Subacute combined degeneration of the spinal cord. Brain. 1900. 23:39.

6. Minot GR, Murphy WP. Treatment of pernicious anemia by a special diet. JAMA. 1926. 87:470-476.

7. Castle WB. Extrinsic factor in pernicious anemia. American Journal of Medical Science. 1929. 178:148.

8. Lassen HCA, Henricksen E, Neukirch F. Treatment of tetanus: severe bone marrow depression after prolonged nitrous oxide anesthesia. Lancet. 1956. 1:527-530.

9. Sahenk Z, Mendell JR, Couri D. Polyneuropathy from inhalation of N2O cartridges through a whipped-cream dispenser. Neurology. 1978 May. 28(5):485-7. [QxMD MEDLINE Link].

10. Layzer RB. Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet. 1978 Dec 9. 2(8102):1227-30. [QxMD MEDLINE Link].

11. Nielsen MJ, Rasmussen MR, Andersen CB, Nexø E, Moestrup SK. Vitamin B12 transport from food to the body's cells--a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol. 2012 May 1. 9(6):345-54. [QxMD MEDLINE Link].

12. Leishear K, Ferrucci L, Lauretani F, Boudreau RM, Studenski SA, Rosano C, et al. Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs. J Gerontol A Biol Sci Med Sci. 2012 May. 67(5):537-43. [QxMD MEDLINE Link]. [Full Text].

13. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Topolski R. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med. 2009 Sep-Oct. 22(5):528-34. [QxMD MEDLINE Link].

14. Nachum-Biala Y, Troen AM. B-vitamins for neuroprotection: narrowing the evidence gap. Biofactors. 2012 Mar-Apr. 38(2):145-50. [QxMD MEDLINE Link].

15. Leishear K, Ferrucci L, Lauretani F, Boudreau RM, Studenski SA, Rosano C, et al. Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs. J Gerontol A Biol Sci Med Sci. 2012 May. 67(5):537-43. [QxMD MEDLINE Link]. [Full Text].

16. Misra UK, Kalita J. Comparison of clinical and electrodiagnostic features in B12 deficiency neurological syndromes with and without antiparietal cell antibodies. Postgrad Med J. 2007 Feb. 83(976):124-7. [QxMD MEDLINE Link].

17. Schilling RF. Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects?. JAMA. 1986 Mar 28. 255(12):1605-6. [QxMD MEDLINE Link].

18. Kinsella LJ, Green R. Anesthesia paresthetica': nitrous oxide-induced cobalamin deficiency. Neurology. 1995 Aug. 45(8):1608-10. [QxMD MEDLINE Link].

19. Healton EB, Savage DG, Brust JC. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991 Jul. 70(4):229-45. [QxMD MEDLINE Link].

20. Woltmann HW. The nervous symptoms in pernicious anemia: an analysis of one hundred and fifty cases. American Journal of Medical Science. 1919. 173:400-9.

21. Dynes JB, Norcross JW. Peripheral neuritis as a complication of pernicious anemia. JAMA. 1943. 122:586-8.

22. Steiner I, Kidron D, Soffer D. Sensory peripheral neuropathy of vitamin B12 deficiency: a primary demyelinating disease?. J Neurol. 1988 Jan. 235(3):163-4. [QxMD MEDLINE Link].

23. Greenfield JG. Subacute spinocerebellar degeneration occurring in elderly patients. Brain. 1934. 57:161-76.

24. McCombe PA, McLeod JG. The peripheral neuropathy of vitamin B12 deficiency. J Neurol Sci. 1984 Oct. 66(1):117-26. [QxMD MEDLINE Link].

25. Coers C, Woolf AL. The Innervation of Muscle. Oxford, England: Blackwell Scientific; 1959. 91.

26. Dalla Torre C, Lucchetta M, Cacciavillani M, Campagnolo M, Manara R, Briani C. Reversible isolated sensory axonal neuropathy due to cobalamin deficiency. Muscle Nerve. 2012 Mar. 45(3):428-30. [QxMD MEDLINE Link].

27. van Loon M, Postels DG, Heikens GT, Molyneux E. Severe pernicious anaemia in an 8-year-old African girl. Ann Trop Paediatr. 2009 Sep. 29(3):231-4. [QxMD MEDLINE Link].

28. Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009 Nov 7. 15(41):5121-8. [QxMD MEDLINE Link]. [Full Text].

29. Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZM. Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med. Oct 2006. 21(10):1063-8. [QxMD MEDLINE Link].

30. Adachi H, Hirai Y, Fujiura Y. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke. 2002 Sep. 33(9):2177-81. [QxMD MEDLINE Link].

31. Addison T. Anemia: Disease of the suprarenal capsules. London Med Gazette. 1849. 8:517-518.

32. Al-Shubaili AF, Farah SA, Hussein JM, et al. Axonal and demyelinating neuropathy with reversible proximal conduction block, an unusual feature of vitamin B12 deficiency. Muscle Nerve. 1998 Oct. 21(10):1341-3. [QxMD MEDLINE Link].

33. Allen RH, Stabler SP, Savage DG. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J. 1993 Nov. 7(14):1344-53. [QxMD MEDLINE Link].

34. Andres E, Noel E, Kaltenbach G. [Vitamin B12 deficiency with normal Schilling test or non-dissociation of vitamin B12 and its carrier proteins in elderly patients. A study of 60 patients]. Rev Med Interne. 2003 Apr. 24(4):218-23. [QxMD MEDLINE Link].

35. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999. 19:357-77. [QxMD MEDLINE Link].

36. Balducci L. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J Am Geriatr Soc. 2003 Mar. 51(3 Suppl):S2-9. [QxMD MEDLINE Link].

37. Beach RS, Mantero-Atienza E, Shor-Posner G. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992 Jul. 6(7):701-8. [QxMD MEDLINE Link].

38. Berger JR, Quencer R. Reversible myelopathy with pernicious anemia: clinical/MR correlation. Neurology. 1991 Jun. 41(6):947-8. [QxMD MEDLINE Link].

39. Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ. 2000 Jul 11. 163(1):21-9. [QxMD MEDLINE Link].

40. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4. 274(13):1049-57. [QxMD MEDLINE Link].

41. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996 May 27. 156(10):1097-100. [QxMD MEDLINE Link].

42. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol. 1992 Jul. 89(1):74-7. [QxMD MEDLINE Link].

43. Carmel R, Gott PS, Waters CH. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 1995 Apr. 54(4):245-53. [QxMD MEDLINE Link].

44. Carmel R, Johnson CS. Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N Engl J Med. 1978 Mar 23. 298(12):647-50. [QxMD MEDLINE Link].

45. Carmel R, Johnson CS, Weiner JM. Pernicious anemia in Latin Americans is not a disease of the elderly. Arch Intern Med. 1987 Nov. 147(11):1995-6. [QxMD MEDLINE Link].

46. Chanarin I. The Megaloblastic Anemias. 2nd ed. Oxford, England: Blackwell Scientific; 1979.

47. Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998 Nov. 55(11):1449-55. [QxMD MEDLINE Link].

48. Cole M. Neurological manifestation of vitamin B12 deficiency. Goetz C, Aminoff M, eds. Handbook of Clinical Neurology. Vol 26. Systemic Diseases. Part II. Amsterdam, Holland: Elsevier Science BV; 1998: 367-405.

49. Combe JJ. History of a case of anemia. Trans Med Chir Soc Edimb. 1822. 1:194-204.

50. Cunha UG, Rocha FL, Peixoto JM. Vitamin B12 deficiency and dementia. Int Psychogeriatr. 1995 Spring. 7(1):85-8. [QxMD MEDLINE Link].

51. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995 Dec 6. 274(21):1698-702. [QxMD MEDLINE Link].

52. Dana CL. Subacute combined sclerosis of the spinal cord and its relation to anemia and to toxemia. J Nerv Ment Dis. 1899. 26:1.

53. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol. 2000 Oct. 57(10):1422-7. [QxMD MEDLINE Link].

54. Ehrenpreis ED, Carlson SJ, Boorstein HL. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci. 1994 Oct. 39(10):2159-62. [QxMD MEDLINE Link].

55. Fenwick S. On atrophy of the stomach. Lancet. 1870. ii:78-80.

56. Fine EJ, Hallett M. Neurophysiological study of subacute combined degeneration. J Neurol Sci. 1980 Mar. 45(2-3):331-6. [QxMD MEDLINE Link].

57. Fine EJ, Soria E, Paroski MW. The neurophysiological profile of vitamin B12 deficiency. Muscle Nerve. 1990 Feb. 13(2):158-64. [QxMD MEDLINE Link].

58. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr. 1998 Apr. 157 Suppl 2:S60-6. [QxMD MEDLINE Link].

59. Goodman BP, Chong BW, Patel AC, Fletcher GP, Smith BE. Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. AJNR Am J Neuroradiol. 2006 Nov-Dec. 27(10):2112-4. [QxMD MEDLINE Link].

60. Graham D, Lantos P. Vitamin Deficiencies. In: Greenfield's Neuropathology. 6th ed. London, England:. Arnold Publishers. 1997:621-624.

61. Grattan-Smith PJ, Wilcken B, Procopis PG. The neurological syndrome of infantile cobalamin deficiency: developmental regression and involuntary movements. Mov Disord. 1997 Jan. 12(1):39-46. [QxMD MEDLINE Link].

62. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995 Aug. 45(8):1435-40. [QxMD MEDLINE Link].

63. Greenfield JG, Carmichael EA. Peripheral nerves in cases of subacute combined degeneration of the cord. Brain. 1935. 58:483-91.

64. Gueant JL, Saunier M, Gastin I. Decreased activity of intestinal and urinary intrinsic factor receptor in Grasbeck-Imerslund disease [corrected]. Gastroenterology. 1995 Jun. 108(6):1622-8. [QxMD MEDLINE Link].

65. Hamilton AS, Nixon CE. Sensory changes in the subacute combined degeneration of pernicious anemia. Arch Neurol Psychiatry. 1921. 6:1.

66. Hemmer B, Glocker FX, Schumacher M, et al. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry. 1998 Dec. 65(6):822-7. [QxMD MEDLINE Link].

67. Hennerici M. Dissociated foveal and parafoveal visual evoked responses in subacute combined degeneration. Arch Neurol. 1985 Feb. 42(2):130-2. [QxMD MEDLINE Link].

68. Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer. 1993 Feb 1. 71(3):745-50. [QxMD MEDLINE Link].

69. Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry. 1997 Nov-Dec. 38(6):305-14. [QxMD MEDLINE Link].

70. Jacques PF, Rosenberg IH, Rogers G, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 1999 Mar. 69(3):482-9. [QxMD MEDLINE Link].

71. Janson JJ, Galarza CR, Murua A. Prevalence of hyperhomocysteinemia in an elderly population. Am J Hypertens. 2002 May. 15(5):394-7. [QxMD MEDLINE Link].

72. Kagan BL, Sultzer DL, Rosenlicht N. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 1990 May. 147(5):591-5. [QxMD MEDLINE Link].

73. Kang SS, Wong PW, Zhou JM, Cook HY. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women. Metabolism. 1986 Oct. 35(10):889-91. [QxMD MEDLINE Link].

74. Kapadia CR. Vitamin B12 in health and disease: part I--inherited disorders of function, absorption, and transport. Gastroenterologist. 1995 Dec. 3(4):329-44. [QxMD MEDLINE Link].

75. Kaptan K, Beyan C, Ural AU. Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency?. Arch Intern Med. 2000 May 8. 160(9):1349-53. [QxMD MEDLINE Link].

76. Karlsson FA, Burman P, Loof L. Enzyme-linked immunosorbent assay of H+,K+-ATPase, the parietal cell antigen. Clin Exp Immunol. 1987 Dec. 70(3):604-10. [QxMD MEDLINE Link].

77. Karnaze DS, Carmel R. Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin. Arch Neurol. 1990 Sep. 47(9):1008-12. [QxMD MEDLINE Link].

78. Katsaros VK, Glocker FX, Hemmer B, Schumacher M. MRI of spinal cord and brain lesions in subacute combined degeneration. Neuroradiology. 1998 Nov. 40(11):716-9. [QxMD MEDLINE Link].

79. Kieburtz KD, Giang DW, Schiffer RB, Vakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. Arch Neurol. 1991 Mar. 48(3):312-4. [QxMD MEDLINE Link].

80. Kirke PN, Molloy AM, Daly LE. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov. 86(11):703-8. [QxMD MEDLINE Link].

81. Krumholz A, Weiss HD, Goldstein PJ, Harris KC. Evoked responses in vitamin B12 deficiency. Ann Neurol. 1981 Apr. 9(4):407-9. [QxMD MEDLINE Link].

82. Larner AJ, Zeman AZ, Allen CM. MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency. J Neurol Neurosurg Psychiatry. 1997 Jan. 62(1):99-100. [QxMD MEDLINE Link].

83. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord. 1999 Jan-Feb. 10(1):12-20. [QxMD MEDLINE Link].

84. Lester-Smith E. Purification of antipernicious amaemia factors from liver. Nature. 1948. 161:638-639.

85. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994 Jul. 60(1):2-11. [QxMD MEDLINE Link].

86. Lindenbaum J, Savage DG, Stabler SP. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990 Jun. 34(2):99-107. [QxMD MEDLINE Link].

87. Magnaghi V, Veber D, Morabito A. Decreased GFAP-mRNA expression in spinal cord of cobalamin-deficient rats. FASEB J. 2002. 16:1820-1822. [QxMD MEDLINE Link].

88. Marie RM, Le Biez E, Busson P, et al. Nitrous oxide anesthesia-associated myelopathy. Arch Neurol. 2000 Mar. 57(3):380-2. [QxMD MEDLINE Link].

89. Metz J. Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr. 1992. 12:59-79. [QxMD MEDLINE Link].

90. Metz J. Pathogenesis of cobalamin neuropathy: deficiency of nervous system S-adenosylmethionine?. Nutr Rev. 1993 Jan. 51(1):12-5. [QxMD MEDLINE Link].

91. Ozer EA, Turker M, Bakiler AR. Involuntary movements in infantile cobalamin deficiency appearing after treatment. Pediatr Neurol. 2001 Jul. 25(1):81-3. [QxMD MEDLINE Link].

92. Paltiel O, Falutz J, Veilleux M. Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol. 1995 Aug. 49(4):318-22. [QxMD MEDLINE Link].

93. Pant SS, Asbury AK, Richardson EP Jr. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol Scand. 1968. 44:Suppl 5:1-36. [QxMD MEDLINE Link].

94. Penix LP. Ischemic strokes secondary to vitamin B12 deficiency-induced hyperhomocystinemia. Neurology. 1998 Aug. 51(2):622-4. [QxMD MEDLINE Link].

95. Perros P, Singh RK, Ludlam CA, Frier BM. Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease. Diabet Med. 2000 Oct. 17(10):749-51. [QxMD MEDLINE Link].

96. Platica O, Janeczko R, Quadros EV. The cDNA sequence and the deduced amino acid sequence of human transcobalamin II show homology with rat intrinsic factor and human transcobalamin I. J Biol Chem. 1991 Apr 25. 266(12):7860-3. [QxMD MEDLINE Link].

97. Postiglione A, Milan G, Ruocco A. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer''s dementia. A case-control study. Gerontology. 2001 Nov-Dec. 47(6):324-9. [QxMD MEDLINE Link].

98. Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc. 1994 Feb. 69(2):144-50. [QxMD MEDLINE Link].

99. Putnam JJ. A group of cases of systemic scleroses of the spinal cord, associated with diffuse collateral degeneration, occurring in enfeebled persons past middle life, especially in women: Studied with particular reference to etiology. J Nerv Ment Dis. 1891. 16:69.

100. Remacha AF, Cadafalch J. Cobalamin deficiency in patients infected with the human immunodeficiency virus. Semin Hematol. 1999 Jan. 36(1):75-87. [QxMD MEDLINE Link].

101. Renault F, Verstichel P, Ploussard JP. Neuropathy in two cobalamin-deficient breast-fed infants of vegetarian mothers. Muscle Nerve. 1999 Feb. 22(2):252-4. [QxMD MEDLINE Link].

102. Richmond J, Davidson S. Subacute combined degeneration of the spinal cord in non-Addisonian megaloblastic anaemia. Quarterly Journal of Medicine. 1958. 27:517-531.

103. Rickes EL, Brink NG, Koniuszy FR. Crystalline vitamin B 12. Science. 1948. 107:396.

104. Robertson KR, Stern RA, Hall CD. Vitamin B12 deficiency and nervous system disease in HIV infection. Arch Neurol. 1993 Aug. 50(8):807-11. [QxMD MEDLINE Link].

105. Sacco RL, Roberts JK, Jacobs BS. Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology. 1998. 17(4):167-73. [QxMD MEDLINE Link].

106. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. 1995 Sep. 8(3):657-78. [QxMD MEDLINE Link].

107. Savage DG, Lindenbaum J, Stabler SP. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994 Mar. 96(3):239-46. [QxMD MEDLINE Link].

108. Scalabrino G, Carpo M, Bamonti F. High tumor necrosis factor-alpha [corrected] levels in cerebrospinal fluid of cobalamin-deficient patients. Ann Neurol. 2004. 56:886-890. [QxMD MEDLINE Link].

109. Scalabrino G, Corsi MM, Veber D. Cobalamin (vitamin B(12)) positively regulates interleukin-6 levels in rat cerebrospinal fluid. J Neuroimmunol. 2002. 127:37-43. [QxMD MEDLINE Link].

110. Scalabrino G, Mutti E, Veber D. Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency. Neurosci Lett. 2006 Mar 27. 396(2):153-8. [QxMD MEDLINE Link].

111. Scott E. The prevalence of pernicious anemia in Britain. J Coll Gen Pract Res News. 1960. 3:80-4.

112. Scott JM. Folate and vitamin B12. Proc Nutr Soc. 1999 May. 58(2):441-8. [QxMD MEDLINE Link].

113. Selhub J, D'Angelo A. Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost. 1997 Jul. 78(1):527-31. [QxMD MEDLINE Link].

114. Stabler SP, Allen RH, Fried LP, et al. Racial differences in prevalence of cobalamin and folate deficiencies in disabled elderly women. Am J Clin Nutr. 1999 Nov. 70(5):911-9. [QxMD MEDLINE Link].

115. Stabler SP, Allen RH, Savage DG. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990 Sep 1. 76(5):871-81. [QxMD MEDLINE Link].

116. Stacy CB, Di Rocco A, Gould RJ. Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy. J Neurol. 1992 Aug. 239(7):401-3. [QxMD MEDLINE Link].

117. Sumner AE, Chin MM, Abrahm JL, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med. 1996 Mar 1. 124(5):469-76. [QxMD MEDLINE Link].

118. Surtees R. Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain. J Inherit Metab Dis. 1993. 16(4):762-70. [QxMD MEDLINE Link].

119. Tan SV, Guiloff RJ. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiatry. 1998 Jul. 65(1):23-8. [QxMD MEDLINE Link].

120. Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc. 1994 Feb. 69(2):181-6. [QxMD MEDLINE Link].

121. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997 Nov 13. 337(20):1441-8. [QxMD MEDLINE Link].

122. Tracey JP, Schiffman FJ. Magnetic resonance imaging in cobalamin deficiency. Lancet. 1992 May 9. 339(8802):1172-3. [QxMD MEDLINE Link].

123. Van der Mooren MJ, Wouters MG, Blom HJ, et al. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest. 24(11):733-6. [QxMD MEDLINE Link].

124. Victor M. Polyneuropathy due to nutritional deficiency and alcoholism. Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Philadelphia, Pa: WB Saunders; 1975: 1030.

125. Wadia RS, Bandishti S, Kharche M. B12 and folate deficiency: incidence and clinical features. Neurol India. 2000 Dec. 48(4):302-4. [QxMD MEDLINE Link].

126. Wang HX, Wahlin A, Basun H. Vitamin B(12) and folate in relation to the development of Alzheimer''s disease. Neurology. 2001 May 8. 56(9):1188-94. [QxMD MEDLINE Link].

127. Weir DG, Scott JM. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999. 55(3):669-82. [QxMD MEDLINE Link].

128. Wilhelm H, Grodd W, Schiefer U. Uncommon chiasmal lesions: demyelinating disease, vasculitis, and cobalamin deficiency. Ger J Ophthalmol. 1993. 2(4-5):234-40. [QxMD MEDLINE Link].

129. Wright JD, Bialostosky K, Gunter EW, et al. Blood folate and vitamin B12: United States, 1988-94. Vital Health Stat 11. 1998 Dec. (243):1-78. [QxMD MEDLINE Link].

130. Yao Y, Yao SL, Yao SS. Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract. 1992 Nov. 35(5):524-8. [QxMD MEDLINE Link].

131. Yoo JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke. 1998 Dec. 29(12):2478-83. [QxMD MEDLINE Link].

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM Adjunct Associate Professor of Neurology, University of Missouri-Columbia School of Medicine; Medical Director of St Mary's Stroke Program, SSM Neurosciences Institute, SSM Health

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Headache Society

Disclosure: Nothing to disclose.

Florian P Thomas, MD, PhD, MA, MS Chair, Neuroscience Institute and Department of Neurology, Director, Hereditary Neuropathy Center, Co-Director, Center for Memory Loss and Brain Health, Co-Director, ALS Center, Hackensack University Medical Center; Associate Dean of Faculty, Founding Chair and Professor, Department of Neurology, Hackensack Meridian School of Medicine

Florian P Thomas, MD, PhD, MA, MS is a member of the following medical societies: Academy of Spinal Cord Injury Professionals, American Academy of Neurology, American Neurological Association, Consortium of Multiple Sclerosis Centers, National Multiple Sclerosis Society, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Alan L Diamond, DO Movement Disorder Fellow, Department of Neurology, Baylor College of Medicine

Alan L Diamond, DO is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Osteopathic Association, American Society of Neuroimaging

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Nestor Galvez-Jimenez, MD, MSc, MHA The Pauline M Braathen Endowed Chair in Neurology, Chairman, Department of Neurology, Program Director, Movement Disorders, Department of Neurology, Division of Medicine, Cleveland Clinic Florida

Nestor Galvez-Jimenez, MD, MSc, MHA is a member of the following medical societies: American Academy of Neurology, American College of Physicians, International Parkinson and Movement Disorder Society

Disclosure: Nothing to disclose.

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida Morsani College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, American Medical Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Bioserenity, Ceribell, Eisai, Jazz, LivaNova, Neurelis, Neuropace, SK life science, Sunovion, Takeda, UCB<br/>Serve(d) as a speaker or a member of a speakers bureau for: Aquestive, Bioserenity, Eisai, Jazz, LivaNova, Neurelis, SK life science, Stratus, Sunovion, UCB<br/>Received research grant from: Cerevel Therapeutics, Ovid Therapeutics, Neuropace, Greenwich Jazz, SK Life Science, Xenon Pharmaceuticals, UCB, Marinus, Neuroelectrics Corporation, Longboard, Janssen, Equilibre Biopharmaceuticals.

Christopher Luzzio, MD Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison School of Medicine and Public Health

Christopher Luzzio, MD is a member of the following medical societies: American Academy of Neurology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article